Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
S-1
IPO registration
23 Apr 24
PRE 14A
Preliminary proxy
16 Apr 24
8-K
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
9 Apr 24
424B5
Prospectus supplement for primary offering
5 Apr 24
424B5
Prospectus supplement for primary offering
5 Apr 24
10-K
2023 FY
Annual report
1 Mar 24
8-K
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
1 Mar 24
S-8
Registration of securities for employees
2 Feb 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
20 Dec 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Biodesix Announces Third Quarter 2023 Results and Highlights
7 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Biodesix Announces Second Quarter 2023 Results and Highlights
7 Aug 23
8-K
Other Events
26 Jul 23
SC TO-I/A
Issuer tender offer statement (amended)
26 Jul 23
SC TO-I/A
Issuer tender offer statement (amended)
3 Jul 23
CORRESP
Correspondence with SEC
3 Jul 23
UPLOAD
Letter from SEC
28 Jun 23
SC TO-I
Issuer tender offer statement
23 Jun 23
8-K
Departure of Directors or Certain Officers
6 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
8-K
Biodesix Announces First Quarter 2023 Results and Highlights
11 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
12 Apr 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
PRE 14A
Preliminary proxy
31 Mar 23
10-K
2022 FY
Annual report
6 Mar 23
8-K
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights
6 Mar 23
S-8
Registration of securities for employees
2 Feb 23
8-K
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors
16 Dec 22
8-K
Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million
21 Nov 22
424B5
Prospectus supplement for primary offering
18 Nov 22
424B5
Prospectus supplement for primary offering
16 Nov 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Biodesix Announces Third Quarter 2022 Results and Highlights
3 Nov 22
8-K
Biodesix Announces Preliminary Revenue for Third Quarter 2022
11 Oct 22
Latest ownership filings
SC 13D/A
PATIENCE JOHN
9 Apr 24
SC 13D/A
Strobeck Matthew
9 Apr 24
SC 13D/A
Kennedy Lawrence T. Jr
9 Apr 24
SC 13D/A
SCHULER JACK W
9 Apr 24
4
Chris Vazquez
9 Apr 24
4
Matthew Strobeck
9 Apr 24
4
JACK W SCHULER
9 Apr 24
4
Gary Anthony Pestano
9 Apr 24
4
JOHN PATIENCE
9 Apr 24
4
Kieran O'Kane
9 Apr 24
4
Lawrence T. Kennedy Jr
9 Apr 24
4
Scott Hutton
9 Apr 24
4
Robin Harper Cowie
9 Apr 24
4
Charles M Watts
3 Apr 24
4
Chris Vazquez
29 Feb 24
4
Gary Anthony Pestano
29 Feb 24
4
Kieran O'Kane
29 Feb 24
4
Scott Hutton
29 Feb 24
4
Robin Harper Cowie
29 Feb 24
4
Chris Vazquez
12 Feb 24
4
Gary Anthony Pestano
12 Feb 24
4
Kieran O'Kane
12 Feb 24
4
Scott Hutton
12 Feb 24
4
Robin Harper Cowie
12 Feb 24
144
Notice of proposed sale of securities
9 Feb 24
144
Notice of proposed sale of securities
9 Feb 24
144
Notice of proposed sale of securities
9 Feb 24
144
Notice of proposed sale of securities
9 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
4
Charles M Watts
3 Jan 24
4
Matthew Strobeck
3 Jan 24
4
JACK W SCHULER
3 Jan 24
4
HANY MASSARANY
3 Jan 24
4
Lawrence T. Kennedy Jr
3 Jan 24
4
Jon Faiz Kayyem
3 Jan 24
4
Jean M. Franchi
3 Jan 24
4
JOHN PATIENCE
3 Jan 24
4
Chris Vazquez
13 Nov 23
4
Gary Anthony Pestano
13 Nov 23
4
Kieran O'Kane
13 Nov 23